Bone Biologics Corp (BBLG) Live Share Price, Invest From India

Bone Biologics Corp Stock Performance

as on March 21, 2026 at 6:56 am IST

Day's Low
Day's High
$1.15
Day's Price Range
$1.21
$1.16
0.86%
Downside
4.31%
Upside
52 Week's Low
52 Week's High
$1.11
52-Week Price Range
$6.75
$1.16
4.31%
Downside
481.90%
Upside

Bone Biologics Corp share price movements today

Previous Close: $1.16
Open: $1.17
Volume: 130.9K
Day's Low - High: $1.15 - $1.21
52 Week Low - High: $1.11 - $6.75

Bone Biologics Corp Historical Returns

1 Month Return: -3.33 %
3 Month Return: -36.61 %
1 Year Return: -78.03 %
3 Year Return: -99.66 %
5 Year Return: 0 %

Bone Biologics Corp Stock Fundamentals & Key Indicators

Check Bone Biologics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1M

EPS (TTM)

-1.93

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-825.0K

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-70.17%

Bone Biologics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bone Biologics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bone Biologics Corp	BUY	$2.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.3B	116.54%	133.52	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$116.3B	110.08%	29.94	32.94%
Beone Medicines Ltd	NA	$32.5B	NA	114.93	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	54.71%	17.8	31.41%

Stock Returns calculator for Bone Biologics Corp Stock including INR - Dollar returns

The Bone Biologics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bone Biologics Corp investment value today

Current value as on today

₹30,516

Returns

₹69,484

(-69.48%)

Returns from Bone Biologics Corp Stock

₹78,030 (-78.03%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Bone Biologics Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bone Biologics Corp. Average target price of $22.2

Bone Biologics Corp Share Price Target

Get share price movements and forecasts by analysts on Bone Biologics Corp.

What analysts predicted

94.77%UPSIDE

Target Price

$22.2

Current Price

$1.16

Analyzed by

7 Analysts

Target

$22.20

Bone Biologics Corp target price $22.2, a slight upside of 94.77% compared to current price of $1.16. According to 7 analysts rating.

Bone Biologics Corp Stock’s Investor Sentiment and Interest

Search interest for Bone Biologics Corp Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 19, 2026 to March 21, 2026

Change:-68% versus previous 30 day period

Bone Biologics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-1	0	0	0	-1	-1	0	0	0
EBITDA	-2	0	0	0	0	-1	-1	0	0	-1
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-1	0	0	0	-1	-1	0	0	0
Income Tax Expense	0	0	0	0	-	0	-	-	-	-
Net Income	-1	-1	0	0	0	-1	-1	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Bone Biologics Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	-	-
Operating Income	-20	-2	-2	-2	0	-1	-3	-9	-4	-3
EBITDA	-20	-2	-2	-2	0	0	0	0	0	-3
Interest Expense	2	4	1	0	0	0	0	2	-	-
Depreciation	-	0	0	0	-	-	-	-	-	-
Income Before Tax	-21	-7	-4	-3	-1	-1	-1	-8	-4	-3
Income Tax Expense	0	0	0	0	0	0	-2	-2	-7	-
Net Income	-25	-7	-4	-3	-1	-1	-1	-8	-4	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Bone Biologics Corp Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	0	0	0	-1	-1	0	0	0
Operating Cash Flow	-2	-1	0	0	-1	0	0	0	0
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	1	0	1	1	0	4	-	-
Change in Cash	-1	0	0	1	0	0	3	0	0

Bone Biologics Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-4	-3	-1	-1	-1	-8	-4	-3
Operating Cash Flow	-3	-4	-3	0	-1	-3	-9	-4	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	4	2	0	7	4	5	4	4
Change in Cash	0	0	0	0	6	0	-4	0	2

Global Institutional Holdings in Bone Biologics Corp

Funds	Holdings
HRT FINANCIAL LLC	0%
UBS Group AG	0%
Two Sigma Investments LLC	0.62%
CLEAR STREET LLC.	0.01%
Citadel Advisors Llc	0.6%

See all

Insights on Bone Biologics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Bone Biologics Corp has experienced a drawdown of -99.7%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 96.2%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 89.3%
NEGATIVE IMPACT
Price Dip
In the last 1 year, BBLG stock has moved down by -78.0%

About Bone Biologics Corp

a publicly-held biotechnology company that is a spin off of the musculoskeletal transplant foundation (mtf) using technology discovered and licensed from ucla. bone biologics market and focus is in the regenerative medicine orthobiologics space. bone biologics was founded in 2004 by university of california professors in collaboration with an osaka university professor and a usc surgeon and acquired in 2006 by mtf as the major shareholder, who has been the primary funder since the acquisition. the company’s proprietary, patented platform technology ucb-1™, exclusively licensed from ucla, has met and surpassed existing standards of care outcomes in completed large animal model (sheep and rhesus monkey) studies that have demonstrated that the ucb-1™ technology facilitates superior normal bone growth. the company believes that as a platform technology, ucb-1™ has broad applications in delivering improved outcomes in almost all surgical procedures involved in bone repair and regeneration.

Organisation	Bone Biologics Corp
Headquarters	2 Burlington Woods Drive, Burlington, MA, United States, 01803
Industry	Biotechnology
CEO	Mr. Jeffrey Frelick
E-voting on shares	Click here to vote

Key Management of Bone Biologics Corp

Name	Title
Ms. Deina H. Walsh CPA	Chief Financial Officer
Mr. Jeffrey Frelick	CEO & President

FAQs

What is Bone Biologics Corp share price today?

Bone Biologics Corp share price today is $1.16 as on March 21, 2026 at 1:26 am IST at the close of the market. Bone Biologics Corp share today touched a day high of $1.21 and a low of $1.15.

What is the 52 week high and 52 week low for Bone Biologics Corp share?

Bone Biologics Corp share touched a 52 week high of $6.75 on June 23, 2025 and a 52 week low of $1.11 on February 17, 2026. Bone Biologics Corp stock price today i.e. March 21, 2026 at 1:26 am IST is closed at $1.16,which is 82.81% down from its 52 week high and 4.50% up from its 52 week low.

What is Bone Biologics Corp's market capitalisation today?

Bone Biologics Corp market capitalisation is $0.00T as on March 21, 2026 at 1:26 am IST.

How to invest in Bone Biologics Corp Stock (BBLG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bone Biologics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bone Biologics Corp Shares that will get you 1.2931 shares as per Bone Biologics Corp share price of $1.16 per share as on March 21, 2026 at 1:26 am IST.

What is the minimum amount required to buy Bone Biologics Corp Stock (BBLG) from India?

Indian investors can start investing in Bone Biologics Corp (BBLG) shares with as little as ₹93.708 or $1 (as of March 21, 2026 at 2:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Bone Biologics Corp stock (as per the Rupee-Dollar exchange rate as on March 21, 2026 at 2:39 pm IST). Based on Bone Biologics Corp share’s latest price of $1.16 as on March 21, 2026 at 1:26 am IST, you will get 8.6207 shares of Bone Biologics Corp. Learn more about fractional shares .